Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

NCT04842318 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

789

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: BR for 6 cycles +R for 8 cycles
DRUG: RCHOP for 6 cycles +R for 8 cycles
DRUG: R2 for 6 cycles + R2 maintenance

Sponsor

Ruijin Hospital